Sexual Medicine Society of North America, Inc.

Scientific Program

Thursday Nov. 21 Friday Nov. 22 Saturday Nov. 23 Sunday Nov. 24

Saturday November 23, 2013

Morning

Saturday November 23, 2013: 07:00 am - 05:00 pm @ Foyer Floor 3
Registration/Information Desk Open


Saturday November 23, 2013: 07:00 am - 07:45 am @ La Salle B/C Ballroom - Le Salon
Breakfast in Exhibit Hall


Saturday November 23, 2013: 07:00 am - 03:00 pm @ La Salle B/C Ballroom - Le Salon
Exhibit Hall Open


Saturday November 23, 2013: 07:00 am - 08:00 am @ Les Continents
Non-Moderated Posters - Meet the Authors


Saturday November 23, 2013: 08:00 am - 05:00 pm @ Les Continents
Non-Moderated Posters


Saturday November 23, 2013: 08:00 am - 09:30 am @ La Salle A Ballroom
Session XII - Peyronie's Disease
Chairs: Gerald Brock, MD, FRCS & William O. Brant, MD


Strategies in Accurately Assessing Penile Curvature show presentation
Rafael E. Carrion, MD

Point/Counterpoint: Excision and Grafting: A Dying Procedure show presentation show presentation
Laurence A. Levine, MD
Jason M. Greenfield, MD

Point/Counterpoint: Injection Therapy is the Best Non-Surgical Management for Peyronie's Disease show presentation show presentation
Lawrence S. Hakim, MD, FACS
Martin K. Gelbard, MD

Panel Q & A


Saturday November 23, 2013: 09:30 am - 10:15 am @ La Salle A Ballroom
Session XIII - Ejaculation/Pain
Chairs: Michael A. Perelman, PhD, IF & Hossein Sadeghi-Nejad, MD, FACS


Current Treatment Options for Premature Ejaculation show presentation
Stanley Althof, PhD, IF

Diagnosis and Management of Pelvic Pain show presentation
Robert M. Moldwin, MD

Q & A


Saturday November 23, 2013: 10:15 am - 10:30 am @ La Salle B/C Ballroom - Le Salon
Break - Visit Exhibits


Saturday November 23, 2013: 10:30 am - 11:45 am @ Cabildo Room
Session XIV A (Concurrent Session) - Female Sexual Dysfunction Symposium
Chairs: Irwin Goldstein, MD & James G. Pfaus, PhD


Central Control of FSD and PGAD show presentation
James G. Pfaus, PhD

Vaginal and Clitoral Basic Science Review show presentation
Noel Kim, PhD

Sexual Pain and Surgery show presentation
Andrew T. Goldstein, MD, IF

HRT Considerations - New Data for Vulvovaginal Atrophy show presentation
James A. Simon, MD, IF

Panel Discussion/Q&A


Saturday November 23, 2013: 10:30 am - 11:45 am @ La Salle A Ballroom
Session XIV B (Concurrent Session) - Changing Paradigms in the Treatment of ED
Chairs: William P. Conners, MD & Lawrence S. Hakim, MD, FACS


Combination PDE5-i Use: Efficacy, Safety, Practice Patterns show presentation
Hossein Sadeghi-Nejad, MD, FACS

Managing Patients with Venous Leak show presentation
Kenneth Mitchell, MPAS, PA-C

Infection Prevention and Management in Prosthetic Surgery Updaten "North American Consensus Document on Infection of Penile Prostheses (NACDIPP)" show presentation
Rabih Darouiche, MD

Panel Discussion
Andrew C. Kramer, MD
John J. Mulcahy, MD
Steven K. Wilson, MD
Gerard D. Henry, MD
Paul E. Perito, MD
Culley C. Carson III, MD
Laurence A. Levine, MD
Francois Eid, MD


Lunch

Saturday November 23, 2013: 11:45 am - 01:15 pm @ Pelican Room
Industry Sponsored Lunch Symposium


Afternoon

Saturday November 23, 2013: 01:15 pm - 02:25 pm @ La Salle A Ballroom
Session XV - Sexual Medicine Education
Chairs: Sue W. Goldstein, BA, IF & Kevin L. Billups, MD


Developing Champions in Sexual Medicine: Update on the Summit on Medical School Education in Sexual Health show presentation show presentation
Sue W. Goldstein, BA, IF
Kevin L. Billups, MD

Training the Next Generation of Sexual Medicine Clinicians show presentation
Andrew C. Kramer, MD

Socioeconomic Update show presentation
William F. Gee, MD

Panel Q & A


Saturday November 23, 2013: 02:25 pm - 02:45 pm @ La Salle B/C Ballroom - Le Salon
Break - Visit Exhibits


Saturday November 23, 2013: 02:45 pm - 04:15 pm @ Pontalba Room
Session XVI A - Concurrent Moderated Posters - Poster Session V - Hypogonadism Part I
Chairs: Tobias Kohler, MD, MPH & Mohit Khera, MD


083 ORAL ENCLOMID (ANDROXAL) RAISES FREE AND TOTAL SERUM TESTOSTERONE IN HYPOGONADAL MEN: COMPARISON WITH A TOPICAL GEL show abstract
Gregory Fontenot, PhD

084 ORAL ENCLOMID (ANDROXAL) RAISES SERUM TESTOSTERONE AND ESTROGEN IN HYPOGONADAL MEN AND MAY HAVE FAVORABLE EFFECTS ON BONE MINERAL DENSITY show abstract
Gregory Fontenot, PhD

085 THE CUPPID TRIAL: CARDIOLOGY CLINIC PATIENTS ARE AT HIGH RISK FOR SYMPTOMATIC HYPOGONADISM show abstract
Bradford Stevenson, MD

086 FREE TESTOSTERONE BY DIRECT AND CALCULATED MEASUREMENT VERSUS EQUILIBRIUM DIALYSIS IN A CLINICAL POPULATION show abstract
Ravi Kacker, MD

087 BONE MINERAL DENSITY AND RESPONSE TO TREATMENT IN TESTOSTERONE DEFICIENT MEN YOUNGER THAN 50 YEARS OLD show abstract
Ravi Kacker, MD

088 INCREASED BODY FAT IS ASSOCIATED WITH HIGHER LH LEVELS IN TESTOSTERONE-DEFICIENT MEN show abstract
Ravi Kacker, MD

089 THE CORRELATION BETWEEN BODY MASS INDEX AND EFFECTIVE TESTOSTERONE REPLACEMENT show abstract
Jessie Gills, MD

090 DOES HYPOGONADISM CONTRIBUTE TO RECURRENT URETHRAL STRICTURE DISEASE? show abstract
Clay Mechlin, MD, MS

091 TIMING OF IMPROVEMENT IN LUTS WITH TESTOSTERONE SUPPLEMENTATION WITHIN THE FIRST SIX MONTHS OF THERAPY show abstract
Charles Welliver, MD

092 VASECTOMY REVERSAL OUTCOMES IN MEN PREVIOUSLY ON TESTOSTERONE REPLACEMENT THERAPY show abstract
Douglas Mata, MPH

093 LOW TOTAL TESTOSTERONE (TT) IS ASSOCIATED WITH HIGHER MORTALITY IN MEN WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD) show abstract
Daniel Shoskes

094 CAN TREATMENT OF NOCTURIA INCREASE TESTOSTERONE LEVEL IN MEN WITH LATE ONSET HYPOGONADISM? show abstract
Jong Wook Kim, PhD

095 ADDING THE AROMATASE INHIBITOR ANASTROZOLE (AZ) TO TESTOSTERONE PELLET (TP) THERAPY PROLONGS THERAPEUTIC TESTOSTERONE (T) LEVELS AND TIME BETWEEN TP INSERTIONS: AN OBSERVATIONAL RETROSPECTIVE STUDY show abstract
Clay Mechlin, MD, MS

096 ASSOCIATION BETWEEN DEPRESSION AND HYPOGONADISM IN MIDDLE-AGED MEN show abstract
Cynara Maceda, MD

097 RETROSPECTIVE STUDY OF THE EFFECT OF ANDROGEL TREATMENT IN HYPOGONADISM ON CONCOMITANT MEDICATION DISCONTINUATION show abstract
Amit Bodhani

098 SALVAGE PHARMACOTHERAPY FOR ORGASMIC DYSFUNCTION AFTER TREATMENT FOR TESTOSTERONE DEFICIENCY show abstract
Ravi Kacker, MD

099 THE IMPACT ON HYPOGONADAL SYMPTOMS OF SWITCHING FROM CLOMIPHENE CITRATE (CC) TO TRANSDERMAL TESTOSTERONE (TDT) show abstract
Boback Berookhim, MD, MBA

100 SAFETY OF TESTOSTERONE THERAPY IN MEN WITH PROSTATE CANCER show abstract
Ravi Kacker, MD


Saturday November 23, 2013: 02:45 pm - 04:15 pm @ Vieux Carré B Room
Session XVI A - Concurrent Moderated Posters - Poster Session VI - Peyronies & Cosmesis
Chairs: John P. Mulhall, MD & Brian S. Christine, MD


101 EFFICACY OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR TREATMENT OF PEYRONIE'S DISEASE BY BASELINE PENILE CURVATURE SEVERITY: TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES show abstract
Larry I. Lipshultz, MD

102 THE EFFECT OF ADJUNCT PENILE TRACTION THERAPY ON CURVATURE, LENGTH, AND CIRCUMFERENCE IN PATIENTS UNDERGOING INTRALESIONAL INJECTION WITH INTERFERON ALPHA-2B FOR PEYRONIE'S DISEASE show abstract
Gregory C. Mitchell, MD, MS

103 DIABETIC AND NON-DIABETIC PEYRONIE'S PATIENTS: EVALUATION OF PRESENTING SYMPTOMS, SURGICAL MANAGEMENT AND OUTCOMES show abstract
Stephen Larsen

104 PHASE 3, OPEN-LABEL STUDY OF THE SAFETY AND EFFECTIVENESS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN MEN WITH PEYRONIE'S DISEASE show abstract
Laurence A. Levine, MD

105 SAFETY PROFILE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF PEYRONIE'S DISEASE WHEN PENILE CURVATURE ?30 OR <30: TWO DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES show abstract
Wayne J.G. Hellstrom, MD

106 LONG-TERM OUTCOMES AND PATIENT SATISFACTION AFTER YACHIA CORPOROPLASTY FOR PEYRONIE'S DISEASE: A SINGLE INSTITUTIONAL REVIEW show abstract
John M. Kelley

107 CLINICAL EVALUATION OF TREATMENT OF PEYRONIE'S DISEASE WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM: ANALYSIS OF PENILE CURVATURE DEFORMITY BY DURATION OF DISEASE AND PLAQUE CALCIFICATION show abstract
Irwin Goldstein, MD

108 INTEGRATED SAFETY PROFILE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN CLINICAL STUDIES EVALUATING THE TREATMENT OF PEYRONIE'S DISEASE show abstract
Culley C. Carson III, MD

109 DORSAL PLICATION WITHOUT DEGLOVING FOR CORRECTION OF ADULT VENTRAL PENILE DEFORMITIES show abstract
Paul H. Chung, MD

110 DETERMINATION OF THE PARENTAL KNOWLEDGE AND BEHAVIORAL PATTERN ON CIRCUMCISION show abstract
Ilhami Surer, MD

111 CROSS-SECTIONAL ANALYSIS OF PENDULOUS, STRETCHED, AND ERECT PENILE LENGTH MEASUREMENTS IN PEYRONIE'S DISEASE show abstract
Wayne J.G. Hellstrom, MD

112 EARLY VERSUS LATE IMPROVEMENT WITH INTRALESIONAL VERAPAMIL THERAPY TO TREAT PEYRONIE'S DISEASE show abstract
Vikram Soni, MD

113 CLINICAL OUTCOMES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN THE TREATMENT OF SUBJECTS WITH PEYRONIE'S DISEASE BY SUBGROUPS: TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES show abstract
Arthur L. Burnett II, MD

114 ERECTILE DYSFUNCTION SECONDARY TO PENILE ARTERY STEAL SYNDROME (PASS) show abstract
Tariq S. Hakky, MD

115 VASECTOMY REVERSAL FOR SEXUAL SYMPTOMS FOLLOWING VASECTOMY show abstract
Mary Samplaski, MD

116 SURVEY OF INTERNATIONAL SOCIETY OF SEXUAL MEDICINE MEMBERS: USE PATTERNS FOR THE VACUUM ERECTION DEVICE show abstract
Hossein Sadeghi-Nejad, MD, FACS

117 MODERN UTILIZATION OF PENILE PROSTHESIS SURGERY: A NATIONAL CLAIMS REGISTRY ANALYSIS show abstract
Robert Segal, MD, FRCS(C)

118 BONE SAW FOR CALCIFIED PEYRONIE'S DISEASE PLAQUES show abstract
Kevin A. Ostrowski, MD


Saturday November 23, 2013: 04:15 pm - 05:45 pm @ Vieux Carré A Room
Session XVI B - Concurrent Moderated Posters - Poster Session VII - Medical Pharmacology
Chairs: Hossein Sadeghi-Nejad, MD, FACS & Nelson Bennett Jr., MD


119 DIRECT EFFECTS OF TADALAFIL ON LOWER URINARY TRACT SYMPTOMS VS INDIRECT EFFECTS MEDIATED THROUGH ERECTILE DYSFUNCTION SYMPTOM IMPROVEMENT: INTEGRATED ANALYSES OF 4 PLACEBO-CONTROLLED CLINICAL STUDIES show abstract
Gerald Brock, MD, FRCS

120 TREATMENT OF LUTS SECONDARY TO BPH WHILE PRESERVING SEXUAL FUNCTION: RANDOMIZED CONTROLLED STUDY OF PROSTATIC URETHRAL LIFT show abstract
Kevin McVary, MD, FACS

121 EFFECTS OF THE ONCE DAILY CO ADMINISTRATION OF TADALAFIL WITH FINASTERIDE FOR 6 MONTHS IN MEN WITH LOWER URINARY TRACT SYMPTOMS AND PROSTATIC ENLARGEMENT SECONDARY TO BENIGN PROSTATIC HYPERPLASIA show abstract
Hartwig Bttner, MD

122 EFFICACY OF TADALAFIL ONCE DAILY FOR TREATMENT OF ERECTILE DYSFUNCTION: THE INFLUENCE OF TESTOSTERONE LEVELS show abstract
Evan Goldfischer, MD, MBA

123 SATISFACTION WITH TADALAFIL OR TAMSULOSIN ONCE DAILY FOR THE TREATMENT OF LUTS/BPH: TREATMENT SATISFACTION SCALE QUESTIONNAIRE RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL show abstract
Angelina Sontag, PhD

124 RANDOMIZED, CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF SILDENAFIL FOR THE TREATMENT OF RECURRENT ISCHEMIC PRIAPISM ASSOCIATED WITH SICKLE CELL DISEASE show abstract
Arthur L. Burnett II, MD

125 ERECTOGENIC EFFECT OF AVANAFIL WITHIN 15 MINUTES OF DOSING IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION show abstract
Irwin Goldstein, MD

126 EFFICACY OF AS NEEDED PDE5 INHIBITOR THERAPY VS. TADALAFIL ONCE DAILY ON IMPROVEMENT IN ERECTILE DYSFUNCTION show abstract
Edward Kim, MD

127 AN INVESTIGATION ON CURRENT STATUS AND PUBLIC AWARENESS FOR COUNTERFEIT PHOSPHODIESTERASE TYPE 5 INHIBITORS IN KOREA show abstract
Sang-Kuk Yang, MD, PhD

128 ROLE OF NOCTURNAL PENILE TUMESCENCE AND RIGIDITY IN RESPONSE TO DAILY SILDENAFIL IN PATIENTS WITH ERECTILE DYSFUNCTION DUE TO PELVIC FRACTURE URETHRAL DISRUPTION: A SINGLE-CENTER EXPERIENCE show abstract
Jing Peng, MD

129 EFFECTS OF DEODORANT AND ANTIPERSPIRANT USE AND THE ABSENCE OF HAIR ON THE ABSORPTION OF TESTOSTERONE 2% SOLUTION APPLIED TO THE AXILLAE show abstract
Paula Polzer,

130 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY show abstract
Kevin McVary, MD, FACS

131 EFFICACY OF TADALAFIL ONCE DAILY IN MEN WITH ERECTILE DYSFUNCTION: AN INTEGRATED ANALYSIS OF DATA OBTAINED FROM 1,913 PATIENTS FROM 6 RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL STUDIES show abstract
Hartwig Bttner, MD

132 IMPROVEMENT IN PENILE CURVATURE AND PLAQUE VOLUME AFTER INTRALESIONAL VERAPAMIL THERAPY AS A FUNCTION OF PEYRONIE'S DISEASE SEVERITY show abstract
Saneal Rajanahally,

133 MODIFICATION OF THE INVANCE MALE SLING PROCEDURE: TREATMENT OF STRESS INCONTINENCE AFTER RADICAL PROSTATECTOMY show abstract
Bashar Omarbasha, MD

134 NEUROPHYSIOLOGIC TESTING IN MEN COMPLAINING OF PENILE SEANTION LOSS AFTER FINASTERIDE USE FOR HAIR LOSS show abstract
John Sullivan, MD

135 THE AROMATASE INHIBITOR (AI) ANASTRAZOLE (AZ) INCREASES THE DURATION OF THERAPEUTIC TESTOSTERONE (T) LEVELS AFTER TESTOSTERONE PELLET (TP) INSERTIONS: A RETROSPECTIVE LONGITUDINAL STUDY show abstract
Clay Mechlin, MD, MS

136 THE EFFECT OF CLOMIPHENE CITRATE ON INFERTILE MALES show abstract
Jason Kovac, MD, PhD


Saturday November 23, 2013: 04:15 pm - 05:45 pm @ Acadian Room
Session XVI B - Concurrent Moderated Posters - Poster Session VIII - Implant Part II
Chairs: Culley C. Carson III, MD & Rafael E. Carrion, MD


137 THE MINIMALLY INVASIVE, NO-TOUCH (MINT) TECHNIQUE FOR PENILE IMPLANT SURGERY show abstract
Christopher Love, MBBS

138 OUTCOMES OF ABDOMINAL WALL RESERVOIR PLACEMENT IN INFLATABLE PENILE PROSTHESIS IMPLANTATION: A SAFE AND EFFICACIOUS ALTERNATIVE TO THE SPACE OF RETZIUS show abstract
Doron S. Stember, MD

141 IATROGENIC URETHRAL INJURY DURING PLACEMENT OF PENILE PROSTHESIS, IS IT TRULY AN INDICATION TO ABORT? show abstract
Daniel Martinez, MD

142 INITIAL TWO YEAR EXPERIENCE WITH HIGH SUBMUSCULAR PLACEMENT OF INFLATABLE PENILE PROSTHESIS RESERVOIRS show abstract
Allen F. Morey, MD

143 ECTOPIC RESERVOIR PLACEMENT DOES NOT INCREASE RISK OF IPP COMPLICATIONS show abstract
Tobias Kohler, MD, MPH

144 INCREASE IN AVERAGE AGE OF INFLATABLE PENILE PROTHESIS RECIPIENTS OVER THE PAST 13 YEARS show abstract
Doron S. Stember, MD

145 THE CARRION CAST: AN INTRACORPORAL ANTIMICROBIAL SPACER MADE OF CASO4 USED TO BRIDGE THE GAP BETWEEN EXPLANTATION OF INFECTED PENILE PROSTHESIS AND DELAYED REIMPLANTATION show abstract
Daniel Martinez, MD

146 PERINEAL MINIMALLY INVASIVE TECHNIQUE FOR CYLINDER LENGTH ADJUSTMENT show abstract
Seth D. Cohen, MD, MPH

147 HIGH SUBMUSCULAR VERSUS SPACE OF RETZIUS PLACEMENT OF IPP RESERVOIRS: WHAT ARE SURGEONS SAYING? show abstract
Allen F. Morey, MD

148 INFLATABLE PENILE PROSTHESIS TECHNIQUE AND OUTCOMES AFTER RADIAL FOREARM FREE FLAP NEOPHALLOPLASTY show abstract
Robert Segal, MD, FRCS(C)

149 EXTERNAL TRACTION THERAPY FOR PENILE LENGTH RECOVERY PRIOR TO PROSTHESIS REPLACEMENT- A PROOF OF CONCEPT STUDY show abstract
Benjamin Sherer, MD

150 HIGH PATIENT SATISFACTION OF INFLATABLE PENILE PROSTHESIS WITH SYNCHRONOUS PLICATION FOR CORRECTION OF PEYRONIE'S DISEASE WITH ERECTILE DYSFUNCTION show abstract
Paul H. Chung, MD

151 CORPOROTOMY PLUG TECHNIQUE IN THE MANAGEMENT OF PROXIMAL CORPORAL PERFORATION DURING REVISION PENILE PROSTHESIS SURGERY show abstract
Tariq S. Hakky, MD

152 EFFICACY OF PENILE TRACTION THERAPY AMONG PATIENTS UNDERGOING INTRALESIONAL INTERFERON TREATMENT FOR PEYRONIE'S DISEASE show abstract
Wayne J.G. Hellstrom, MD

153 TRENDS IN SURGICAL APPROACH OF PENILE PROTHESIS SURGERY OVER THE PAST 13 YEARS show abstract
Doron S. Stember, MD

154 SHORTENED PENIS POST PENILE PROSTHESIS IMPLANTATION TREATED WITH SUBCUTANEOUS SOFT SILICONE PENILE IMPLANT: CASE STUDY show abstract
Vaheh Shirvanian, MD


Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (952) 314 8212
info@smsna.org

Address
14305 Southcross Dr
Suite 100
Burnsville, MN 55306